glp-1 and parkinson's Are we measuring the wrong primary outcome for drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1a: Going beyond Traditional Use

Neutrophil invasion is a typical feature in inflammation (Atroshi et al

CJC-1295 and ipamorelin work through two different receptor pathways

For each neighborhood, we identified the number of patients with GLP-1 activity per 10K individuals, the proportion with a type 2 diabetes diagnosis and select patient demographics (i.e., age, gender, insurance source)

This is the tube that moves urine from your bladder out of your body

Furthermore, because praziquantel is highly effective and has low toxicity, it is essential to identify new drugs that can be used in combination with it to prevent parasites from developing resistance

Mature erythrocytes have limited synthetic and repair capacities, but to effectively function they must have biochemical pathways that generate enough energy to support cellular function and allow haemoglobin to be maintained in a state that can effectively bind oxygen